Fraser, Christopher,Kishimoto, Takashi Kei,Maldonado, Roberto A.
申请号：
AU2019232931
公开号：
AU2019232931A1
申请日:
2019.09.20
申请国别(地区):
AU
年份:
2019
代理人:
摘要：
#$%^&*AU2019232931A120191010.pdf#####ABSTRACT Disclosed are synthetic nanocarrier compositions, and related methods, comprising MHC Class II-restricted epitopes and immunosuppressants that provide tolerogenic immune responses, such as a reduction in CD4+ T cell help specific to an antigen.
